Dr. Reddy's Laboratories
242 hedge funds and large institutions have $1.62B invested in Dr. Reddy's Laboratories in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 107 increasing their positions, 61 reducing their positions, and 30 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
75% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 61
20% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 30
11% more capital invested
Capital invested by funds: $1.46B → $1.62B (+$159M)
0.28% less ownership
Funds ownership: 13.16% → 12.88% (-0.28%)
0% less funds holding
Funds holding: 243 → 242 (-1)
53% less call options, than puts
Call options by funds: $14K | Put options by funds: $30K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$51.7M |
| 2 |
BlackRock
New York
|
+$28.1M |
| 3 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$20.7M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$13M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$9.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$55.4M |
| 2 |
Millennium Management
New York
|
-$40.2M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$15.8M |
| 4 |
Jane Street
New York
|
-$11.1M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$10.4M |
RDY Hedge Fund Activity: Q2 2025 in Review
242 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2025, worth a combined $1.62B — up 11% from $1.46B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new RDY positions and 30 closed out — a net gain of 6 holders — while 107 added to existing stakes and 61 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $51.7M. The largest seller was Morgan Stanley, cutting an estimated $55.4M.
- 242 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2025, down from 243 in Q1 2025.
- Funds reported $1.62B of Dr. Reddy's Laboratories stock for Q2 2025, up 11% quarter-over-quarter.
- 36 funds opened new Dr. Reddy's Laboratories positions in Q2 2025 and 30 closed out, a net change of +6 holders.
- The largest Dr. Reddy's Laboratories buyer in Q2 2025 was JP Morgan Chase, an estimated $51.7M added.
- The largest Dr. Reddy's Laboratories seller in Q2 2025 was Morgan Stanley, an estimated $55.4M sold.
Based on aggregated 13F filings for Q2 2025.